ScoreWhy is Nanjing Hicin Pharmaceutical Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 4.33%
- The company has been able to generate a Return on Capital Employed (avg) of 4.33% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -0.39% and Operating profit at 5.03% over the last 5 years
3
Positive results in Mar 26
- NET SALES(HY) At CNY 359.86 MM has Grown at 25.6%
- NET PROFIT(HY) At CNY 42.3 MM has Grown at 55.88%
- DEBT-EQUITY RATIO (HY) Lowest at 21.01 %
4
With ROE of 5.39%, it has a expensive valuation with a 1.87 Price to Book Value
- Over the past year, while the stock has generated a return of -6.56%, its profits have risen by 38% ; the PEG ratio of the company is 0.9
- At the current price, the company has a high dividend yield of 0.3
5
Underperformed the market in the last 1 year
- Even though the market (China Shanghai Composite) has generated returns of 16.83% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -6.56% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Nanjing Hicin Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Nanjing Hicin Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Nanjing Hicin Pharmaceutical Co., Ltd.
-24.96%
2.02
71.93%
China Shanghai Composite
8.25%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-0.39%
EBIT Growth (5y)
5.03%
EBIT to Interest (avg)
6.40
Debt to EBITDA (avg)
1.80
Net Debt to Equity (avg)
0.25
Sales to Capital Employed (avg)
0.42
Tax Ratio
7.88%
Dividend Payout Ratio
28.53%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.91%
ROE (avg)
4.12%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
73
Industry P/E
Price to Book Value
3.93
EV to EBIT
57.01
EV to EBITDA
34.61
EV to Capital Employed
3.42
EV to Sales
6.43
PEG Ratio
1.92
Dividend Yield
0.15%
ROCE (Latest)
6.00%
ROE (Latest)
5.39%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend16What is working for the Company
NET SALES(HY)
At CNY 359.86 MM has Grown at 25.6%
NET PROFIT(HY)
At CNY 42.3 MM has Grown at 55.88%
DEBT-EQUITY RATIO
(HY)
Lowest at 21.01 %
DEBTORS TURNOVER RATIO(HY)
Highest at 3.47 times
RAW MATERIAL COST(Y)
Fallen by 0.84% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 1.94 times
EPS(Q)
Highest at CNY 0.14
-5What is not working for the Company
INTEREST COVERAGE RATIO(Q)
Lowest at 1,242.05
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.36 times
OPERATING PROFIT(Q)
Lowest at CNY 17.96 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 11.2 %
Here's what is working for Nanjing Hicin Pharmaceutical Co., Ltd.
Net Sales
At CNY 359.86 MM has Grown at 25.6%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Net Profit
At CNY 42.3 MM has Grown at 55.88%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Debt-Equity Ratio
Lowest at 21.01 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 3.47 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
EPS
Highest at CNY 0.14
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Inventory Turnover Ratio
Highest at 1.94 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by 0.84% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Nanjing Hicin Pharmaceutical Co., Ltd.
Interest Coverage Ratio
Lowest at 1,242.05
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Operating Profit
Lowest at CNY 17.96 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 11.2 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Inventory Turnover Ratio
Lowest at 1.36 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
